THE IMPORTANCE OF BONE MARROW AND CORD BLOOD BANKING IN THE SEARCH OF UNRELATED STEM CELL DONORS

Yıl 2021, , 249 - 255, 25.04.2021

Fatma Savran Oğuz

https://doi.org/10.26650/IUITFD.2020.0014

Öz

In approximately 30% of the patients who planned to undergo allogeneic stem cell transplantation, HLA-matched donors can be found from either siblings or related donors. For the remaining 70%, the source of healthy donor stem cells are provided by bone marrow or cord blood banks generated by the contribution of volunteer donors. Each country registers the HLA phenotype data of their donors into an international database. The World Marrow Donor Association (WMDA) is the world's largest hematopoietic cell database, listing more than 36 million stem cell donors and over 800,000 cord blood units. It serves as a worldwide network that organizes Hematopoietic Stem Cells (HSC) transplantations from unrelated donors for those in need. WMDA consists of 137 hematopoietic cell donor registries from 55 countries, and 53 cord blood banks from 36 countries. The shared network enables clinicians and other healthcare professionals with a role in donor selection to search all the registries simultaneously around the world. More than 49% of all the stem cell products are delivered across international borders in the hands of licensed couriers. The Istanbul Faculty of Medicine Bone Marrow Bank was the first bank established in Turkey. There are three bone marrow banks (Istanbul University Istanbul Faculty of Medicine Bone Marrow Bank, Ankara University Faculty of Medicine Bone Marrow Bank, and TURKOK-established in the Ministry of Health) in Turkey for a national and international search of donors. The Ankara University Unrelated Cord Blood Bank is the only public bank in Turkey, which has an international accreditation certificate ''FACT NETCORD''.

Anahtar Kelimeler

Stem Cell donor, cord blood banking, stem cell

AKRABA DIŞI KÖK HÜCRE VERİCİSİ ARAŞTIRILMASINDA KEMİK İLİĞİ VE KORDON KANI BANKACILIĞININ ÖNEMİ

Öz

Allojenik kök hücre nakli kararı verilen hastaların yaklaşık %30’unda İnsan Lökosit Antijenleri (HLA) uyumlu kardeş ya da kardeş dışı akraba verici bulunabilmektedir. HLA uyumlu aile içi verici bulunamayan %70 oranında hasta için ise sağlıklı verici kan kök hücre kaynağı, gönüllü vericilerden oluşturulan kemik iliği bankaları ve kordon kanı bankalarından sağlanmaktadır. Her ülke kendi gönüllü vericilerine ait HLA fenotip bilgisini uluslararası bir veri tabanına kaydeder. Dünya Kemik İliği Vericileri Birliği (WMDA), dünya çapında bir ağ oluşturarak, hastalara akraba dışı gönüllü vericilerden Hematopoietik Kök Hücre (HKH) naklini organize eden bir kuruluştur. WMDA, 55 ülkeden 137 HKH verici bankası ve 36 ülkeden 53 kordon kanı bankasından oluşmaktadır. Otuz yedi milyon kök hücre vericisi ve 800 bini WMDA akreditasyonuna sahip bankalara ait olmak üzere toplam 1.042.224 kordon kanı ünitesi listeleyen dünyanın en büyük hematopoietik hücre veri tabanıdır. Ortak veri tabanı, klinisyenlerin ve verici seçiminde yer alan diğer profesyonellerin tüm dünyadaki verici merkezlerini aynı anda tarayabilmelerini sağlar. Gönüllü vericilerden toplanan kök hücrelerin %49’undan fazlası eğitimli kuryeler aracılığı ile uluslararası sınırlardan geçmektedir. İstanbul Tıp Fakültesi Kemik İliği Bankası (KİBANK), Türkiye’de kurulmuş ilk kemik iliği bankasıdır. Ülkemizde, ulusal ve uluslararası veri tabanında uygun verici taramalarını yapmak üzere KİBANK, Ankara Üniversitesi Tıp Fakültesi Kemik İliği Bankası ve Sağlık Bakanlığı bünyesinde kurulmuş TÜRKÖK olmak üzere 3 kemik iliği bankası hizmet vermektedir. Ankara Üniversitesi Akraba Dışı Kordon Kanı Bankası, Türkiye’deki uluslararası akreditasyon sertifikası “FACT NetCord”u sahibi tek akraba dışı kordon bankasıdır.

Anahtar Kelimeler

Kök hücre gönüllü vericisi, kordon kanı bankacılığı, kök hücre

Kaynakça

• 1. Thomas ED. Stem cell transplantation: past, present and future. Stem Cells 1994;12(6):539-44. [CrossRef]
• 2. Hansen JA, Yamamoto K, Petersdorf E, Sasazuki T. The role of HLA matching in hematopoietic cell transplantation. Rev Immunogenet 1999;1(3):359-73.
• 3. González-Galarza F, Takeshita LYC, Santos EJM, Kempson F, et al. Allele frequency net 2015 update: new features for HLA epitopes, KIR and disease and HLA adverse drug reaction associations Nucleic Acids Research 2015;43,784-8. [CrossRef]
• 4. Hurley CK, Wade JA, Oudshoorn M, Middleton D, Kukuruga D, Navarrete C, et al. A special report: histocompatibility-testing guidelines for hematopoietic stem cell transplantation using volunteer donors. Tissue Antigens 1999;53:394-406. [CrossRef]
• 5. Cao K, Hollenbach J, Shi X, Shi W, Chopek M, Fernandez- Vina MA. Analysis of the frequencies of HLA-A, B, and C alleles and haplotypes in the five major ethnic groups of the United States reveals high levels of diversity in these loci and contrasting distribution patterns in these populations. Hum Immunol 2001;62:1009-30. [CrossRef]
• 6. Middleton D, Williams F, Meenagh A, Daar AS, Gorodezky C, Hammond M, et al. Analysis of the distribution of HLA-A alleles in populations from five continents. Hum Immunol 2000;61:1048-52. [CrossRef]
• 7. Machulla HK, Batnasan D, Steinborn F, Uyar FA, Saruhan- Direskeneli G, Oguz FS, et al. Genetic affinities among Mongol ethnic groups and their relationship to Turks. Tissue Antigens 2003;61(4):292-9. [CrossRef]
• 8. Uyar FA, Dorak MT, Saruhan-Direskeneli G. Human leukocyte antigen-A, -B and -C alleles and human leukocyte antigen haplotypes in Turkey: Relationship to other populations. Tissue Antigens 2004;64:180-7. [CrossRef]
• 9. Beatty PG, Dahlberg S, Mickelson EM, Nisperos B, Opelz G, Martin PJ, et al. Probability of finding HLA-matched unrelated marrow donors. Transplantation 1988;45(4):714-8. [CrossRef]
• 10. Hansen JA, Clift RA, Thomas ED, Buckner CD, Storb R, Giblett ER. Transplantation of Marrow from an Unrelated Donor to a Patient with Acute Leukemia. N EngL J Med 1980;303(10):565-7. [CrossRef]
• 11. Aljurf M, Weisdorf D, Alfraih F, Szer J, Müller C, Confer D, Hashmi S, Kröger N. Worldwide Network for Blood & Marrow Transplantation (WBMT) special article, challenges facing emerging alternate donor registries. Bone Marrow Transplant 2019;54(8):1179-88. [CrossRef]
• 12. World Marrow Donor Association (WMDA), International Standards for Unrelated Hematopoietic Stem Cell Donor Registries, WMDA Standards 2020. 2019. (last revised June 6, 2019). Standards 2.03-2.05, 2.07, 2.08, 5.07.
• 13. Foeken LM, Green A, Hurley CK, Marry E, Wiegand T, Oudshoorn M. Monitoring the international use of unrelated donors for transplantation: the WMDA annual reports. Bone Marrow Transplant 2010;45(5):811-8. [CrossRef]
• 14. Gratwohl A, Pasquini MC, Aljurf M, Atsuta Y, Baldomero H, Foeken L, et al. One million haemopoietic stem-cell transplants: a retrospective observational study. Lancet Haematol 2015;2(3):e91-100. [CrossRef]
• 15. Little A-M, Green A, Harvey J, Hemmatpour S, Latham K, Marsh SGE, et al. BSHI Guideline: HLA matching and donor selection for haematopoietic progenitor cell transplantation. Int J Immunogenet 2016;43:263-86. [CrossRef]
• 16. Olson JA, Gibbens Y, Tram K, Kempeninch J, et al. Identification of a 10/10 matched donor for patients with an uncommon haplotype is unlikely. HLA 2017;89(2):77-81. [CrossRef]
• 17. Shem-Tov N, Peczynski C, Labopin M, Itälä-Remes M, Blaise D, Labussière-Wallet H, Nagler A. Haploidentical vs. unrelated allogeneic stem cell transplantation for acute lymphoblastic leukemia in first complete remission: on behalf of the ALWP of the EBMT. Leukemia 2019;34(1):283- 92. [CrossRef]
• 18. National Marrow Donor Program/Be The Match, 24th ed. Standards and Glossary (Last revised January 1, 2018). Standards, 8.6100, 8.6200, 8.6300, 8.6400, 8.6500, 8.7000, 8.8000.
• 19. Rijkers M, Schmidt D, Lu N, Kramer CSM, Heidt S, Mulder A, et al. Anti-HLA antibodies with complementary and synergistic interaction geometries promote classical complement activation on platelets. Haematologica 2019;104(2):403-16. [CrossRef]
• 20. Rebulla P. A mini-review on platelet refractoriness. Haematologica 2005;90(2):247-53.
• 21. Oguz FS, Beksaç M. Kordon Kanı Nakilleri ve insan lökosit antijen uyumu. Hematolog 2016:6(1):82-8.
• 22. Dehn J, Spellman S, Hurley CK, Shaw BE, Barker JN, et al. Selection of unrelated donors and cord blood units for hematopoietic cell transplantation: guidelines from the NMDP/CIBMTR. Blood 2019;134(12);924-34. [CrossRef]
• 23. Ballen KK, Gluckman E, Broxmeyer HE. Umbilical cord blood transplantation: the first 25 years and beyond. Blood 2013; 25;122(4):491-8. [CrossRef]
• 24. Eapen M, Klein JP, Sanz GF, et al. Eurocord-European group for blood and marrow transplantation; Netcord; Center for International Blood and Marrow Transplant Research. Effect of donor-recipient HLA matching at HLA A, B, C, and DRB1 on outcomes after umbilical-cord blood transplantation for leukaemia and myelodysplastic syndrome: a retrospective analysis. Lancet Oncol 2011;12(13):1214-21. [CrossRef]
• 25. Eapen M, Klein JP, Ruggeri A, et al. Impact of allele-level HLA matching on outcomes after myeloablative single unit umbilical cord blood transplantation for hematologic malignancy. Blood 2014;123(1):133-40. [CrossRef]
• 26. Gluckman E, Rocha V, Boyer-Chammard A, Locatelli F, et al. Outcome of cord blood transplantation from related and unrelated donors. Eurocord Transplant Group and the European Blood and Marrow Transplantation Group. N Engl J Med 1997;7;337(6):373-81. [CrossRef]
• 27. Rocha V, Wagner JE Jr, Sobocinski KA, Klein JP, Zhang MJ, Horowitz MM, et al. Graftversus-host disease in children who have received a cord-blood or bone marrow transplant from an HLA identical sibling. Eurocord and International Bone Marrow Transplant Registry Working Committee on Alternative Donor and Stem Cell Sources. N Engl J Med 2000;342(25):1846-54. [CrossRef]
• 28. Rocha V, Labopin M, Sanz G, Arcese W, Schwerdtfeger R, Bosi A, et al. Acute Leukemia Working Party of European Blood and Marrow Transplant Group; Eurocord Netcord Registry. Transplants of umbilical cord blood or bone marrow from unrelated donors in adult with acute. New Engl J Med 2004;351(22):2276-85. [CrossRef]
• 29. Rocha V, Cornish J, Sievers EL, et al. Comparison of outcomes of unrelated bone marrow and umbilical cord blood transplants in children with acute leukemia. Blood 2001;97(10):2962-71. [CrossRef]
• 30. Allan D, Kiernan J, Gragert L, Dibdin N, Bartlett D, et al. Reducing ethnic disparity in access to high-quality HLAmatched cord blood units for transplantation: analysis of the Canadian Blood Services’ Cord Blood Bank inventory. Transfusion 2019;59:2382-8. [CrossRef]